Clinical Trials Contact

About this Clinical Trial

Open Label Two-Arm Study to Evaluate Rilzabrutinib in IgG4-Related Disease Patients

Your Message Will Go To

Angie Aberia

650-723-8516


All fields are required. *

Preferred contact method*

To:

Angie Aberia

650-723-8516



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine